EU-Japan Biotech & Pharma Partnering Conference 2026

16 Sept – 5 Oct 2026 | Osaka, Japan

Alithea Biotechnology GmbH

Company (SME/startup) / 中小企業・スタートアップ

alithea-bio.com/Freiburg im Breisgau, Germany
66 profile visits

About

Alithea Bio is a biotech company advancing precision immunotherapy through AI-enabled immunopeptidomics and innovative peptide discovery technologies. The company develops next-generation solutions for personalized medicine, focusing on the identification and characterization of clinically relevant peptides to support targeted immunotherapies, biomarker discovery, and translational research.

By combining biotechnology, data science, and scalable laboratory innovation, Alithea Bio aims to accelerate the development of more precise and effective therapeutic approaches for cancer and other immune-related diseases. The company is actively building collaborations with pharmaceutical companies, research institutions, and strategic partners across the global biotech ecosystem.

Social media

Areas of activity

Business Type / 業種

R&D / 研究開発

Disease Area / 疾患領域

Oncology / がん

Modalities / モダリティ

Peptide, Protein / ペプチド、タンパク

Business Domain / 分野

Healthcare / ヘルスケア

Technologies / 技術

Biomarkers /バイオマーカーAI・Data analysis / AI・データ分析

Additional information

Researched company/organisation type / マッチングご希望企業・機関のタイプ

Startups, BioTech etc. (In-licensing or Partnership/Collaboration purpose) / 独自の技術やシーズを持つスタートアップ、バイオテック企業等(インライセンス、共同研究などを目的)

Researched disease area / マッチングご希望の疾患領域

Oncology / がん

Researched Modality / マッチングご希望のモダリティ

Peptide, Protein / ペプチド、タンパク

Researched Technologies / マッチングご希望の技術

Biomarkers / バイオマーカーAI・Data analysis/ AI・データ分析